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Abstract
Plasmodium falciparum is unique among human malarias in its ability to sequester in post-capillary venules of host organs.
The main variant antigens implicated are the P. falciparum erythrocyte membrane protein 1 (PfEMP1), which can be divided
into three major groups (A–C). Our study was a unique examination of sequestered populations of parasites for genetic
background and expression of PfEMP1 groups. We collected post-mortem tissue from twenty paediatric hosts with
pathologically different forms of cerebral malaria (CM1 and CM2) and parasitaemic controls (PC) to directly examine
sequestered populations of parasites in the brain, heart and gut. Use of two different techniques to investigate this question
produced divergent results. By quantitative PCR, group A var genes were upregulated in all three organs of CM2 and PC
cases. In contrast, in CM1 infections displaying high levels of sequestration but negligible vascular pathology, there was
high expression of group B var. Cloning and sequencing of var transcript tags from the same samples indicated a uniformly
low expression of group A-like var. Generally, within an organ sample, 1–2 sequences were expressed at dominant levels.
23% of var tags were detected in multiple patients despite the P. falciparum infections being genetically distinct, and two
tags were observed in up to seven hosts each with high expression in the brains of 3–4 patients. This study is a novel
examination of the sequestered parasites responsible for fatal cerebral malaria and describes expression patterns of the
major cytoadherence ligand in three organ-derived populations and three pathological states.
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Introduction
Protection from symptomatic falciparum malaria develops
through successive acquisition of antibodies to variant surface
antigens expressed on host erythrocytes. Severe malaria is thought to
occur in part when a parasite variant exploits a gap in the host
antibody repertoire. The major parasite antigen implicated in this
process is the Plasmodium falciparum erythrocyte membrane
protein 1 (PfEMP1), which is encoded by approximately 60 var
genes per genome that are expressed in mutually exclusive fashion.
This exclusivity shields most of the antigens from the immune system
at any given time, contributing to the incremental accumulation of
host immunity. There is, however, a suggestion that switching
between genes is structured and results in certain genes being
preferentially expressed [1,2,3]. Var genes are mainly clustered in
sub-telomeric regions surrounded by repeat sequences, an arrange-
ment that facilitates high rates of recombination and mutation [4].
The var genes encoding PfEMP1 family members are sub-
divided into three major groups labeled A, B and C based on
motifs in non-coding sequences and locus position, and consist of
characteristic arrangements of adhesive domains [5,6,7]. The two
major domain types are the Duffy-binding like domain (DBL) and
the cysteine-rich interdomain region (CIDR). These domains are
further classified into a series of cassettes with potential biologically
relevant properties, particularly the DC8 and DC13 subset that
adhere promiscuously to diverse endothelial cell types through
endothelial protein receptor C (EPCR; [8,9,10]). The EPCR-
binding var are classified as group A (DC13 and others) or an A/B
chimera (DC8) var [9]. These domains are located in the
extracellular portion of PfEMP1 and are displayed on the surface
of the parasitised red blood cell (pRBC) where they bind to
endothelial receptors on host microvasculature, a process known
as cytoadherence. This process removes pRBC from the circula-
tion, leading to sequestering of pRBC in post-capillary venules
where they thrive in a hypoxic environment and avoid splenic
clearance. In large accumulation, sequestration can lead to
blockage of blood vessels, haemorrhage and formation of thrombi
and, in some cases, migration of monocytes to the point of vascular
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damage, all of these processes being commonly identifiable in the
pathology of paediatric cerebral malaria (CM) [11].
A number of specific binding interactions between endothelial
receptors and PfEMP1 adhesive domains are well established, such
as CIDRa domains adhering to CD36, the DBLb domain binding
to intercellular adhesion molecule-1 (ICAM-1) [12,13,14], and
domain subtypes CIDRa1.1 of DC8-containing PfEMP1 variants
and CIDRa1.4 in DC13 genes with EPCR [9]. Other potential
binding interactions are less well understood although a range of
parasite and host receptors may support pRBC adhesion. The
most striking example is the adherence of a PfEMP1 encoded by
the group E gene, var2csa, to chondroitin sulphate A on
syncytiotrophoblasts in the placenta [15]. The unique nature of
this interaction, restricted to a single organ, raises hopes of using
this var gene in a vaccine specifically targeting malaria in
pregnancy.
The tissue pathology of paediatric cerebral malaria is, by its very
nature, inaccessible to direct study and therefore poorly under-
stood. Studies on circulating parasites have demonstrated that
there is high turnover of the antigens expressed during disease and
in asymptomatic infections [16,17,18] and that severe disease
syndromes are often associated with higher expression of group A
var genes in peripheral blood, albeit inconsistently
[19,20,21,22,23,24]. It has been suggested that two subsets of
group A var are responsible for differing disease manifestations,
with one being associated with respiratory distress and the other
with impaired consciousness [25].
Our work is part of a paediatric malaria clinical and
pathological study in Malawi in which more than 100 children
with fatal encephalopathy, including 73 with clinically-defined
cerebral malaria, have been studied between 1996 and 2011. For
the present study, we have divided the cases into three diagnostic
groups based on their clinical, autopsy and histological features:
CM1, clinically defined CM with cerebral sequestration in the
brain but with no associated vascular pathology; CM2, clinically
defined CM with cerebral sequestration and intra- and peri-
vascular pathology such as ring haemorrhages, thrombi and
infiltration of monocytes; and a third group of parasitaemic
controls (PC) made up of comatose patients with circulating P.
falciparum parasitaemia but minimal sequestration, and a non-
malarial cause of death. This unique study allows us to access
sequestered populations of pRBC to investigate the features of
parasites located in organ microvasculature and to identify the
ligands that may be implicated in cerebral cytoadherence.
Owing to the high diversity of var antigens and, therefore,
unknown contingent of var genes present in clinical P. falciparum
isolates, the methodology for studying their expression in clinical
samples requires the use of degenerate primers. Previous clinical
studies exclusively used peripheral blood samples and one of two
methods: amplification of var transcripts using ‘‘universal’’ primers
that amplify the vast majority of var genes, or more recently,
quantitative real time PCR (qRT-PCR) targeting var groups A, B
or C [19,20,21,22,23,24]. We used both techniques in order to
compare var group expression in these organ-based parasite
populations with contemporary qRT-PCR studies, and also for the
more rich detail supplied by cloning and sequencing of individual
var tags. Our results demonstrate why these methods have not
previously been presented simultaneously using clinical isolates as
their results are starkly contradictory. We present both data sets
here with a discussion of the pros and cons of each approach to
allow readers to make their own judgment on the relative merits of
each.
Results
Patient selection
Twenty patients were selected from the paediatric malaria
study. Their details are in Table 1. At the time of selection, 87
cases of fatal malaria and controls were available. We chose the
patients based on diagnostic classification [26], time between
death and post-mortem examination, storage conditions of the
samples and from data extracted from our pilot study on var
expression [27]. This had raised the possibility of limited diversity
of var genes within a malaria season and so the patients were
chosen at a fixed ratio over five malaria seasons. Among autopsy-
confirmed CM cases, it was previously shown that approximately
two thirds are CM2 and one third CM1 [26], and therefore we
sampled cases at a ratio of 2 CM2: 1 CM1: 1 PC. One PC case
was later revised as CM2 based on final histological examination,
leaving us with a final selection of 11 CM2: 5 CM1: 4 PC.
Restricted genetic diversity of CM patients
Sixteen of the twenty patients were assessed for P. falciparum
genetic diversity in the brain, heart and gut by msp typing and
barcoding (S1 Figure). Four patients were excluded because the
samples had low P. falciparum DNA concentration or failed
extraction. msp2 typing provides the multiplicity of infection
(MOI) with non-quantitative detection of all genetic variants [28].
Barcoding assigns a unique identifier to each infection and
determines whether one of the variants is present at dispropor-
tionately high levels and dominates the infection (monoallelic) or
whether it is a heterogeneously mixed infection (multiallelic)
[29,30].
All of the infections were genetically distinct (S1 Figure). There
was a mean of 2.460.7 genetic variants per patient, and between
1.561.1 and 2.261.1 variants per organ, comparable to
contemporary studies in Malawi [31,32]. There were no
significant differences in MOI between organ types, diagnostic
groups or season. We also did not observe any correlation between
genetic diversity and the density of peripheral parasitaemia.
The proportion of monoallelic infections were 50% for CM2,
40% for CM1 (although patient 37 had only a single heterozygous
call) and 33% for PC cases. Three CM2 cases that were classified
Author Summary
One of the most severe forms of malarial disease is
cerebral malaria, which disproportionally affects young
children. In this disease, the parasite places proteins on the
red blood cell surface, providing a ‘‘smokescreen’’ by
which they evade host immunity and hide in organ blood
vessels, blocking them and causing tissue damage. It is
impossible to study parasites in the organs during life and
autopsy studies on children with malaria are exceedingly
rare. In Malawi, we examined parasites from the brain,
heart and intestine of twenty cases of fatal malaria
including controls with low numbers of malaria parasites
but another identified cause of death. We found little
difference in the category of proteins the parasites used in
controls and cerebral malaria, although a small number of
specific proteins were detected in multiple infections. In an
alternative form of malaria in which the brain is heavily
infected but shows no evidence of damage, we found a
different set of proteins at high proportion. However, as
these children were typically older and most were infected
with HIV, we could not determine which of these factors
was most important. Interactions between host and
parasite have the potential to influence disease outcomes.
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as monoallelic by barcoding were shown to have a second genetic
variant by msp2 typing (patients 28, 68 and 78 in S1 Figure). This
is explained by the higher sensitivity of the msp technique, which is
not quantitative and detects any amount of DNA, whereas
barcoding can overlook variants present at low levels (,5% of
total parasitaemia) [29].
Proportion of var gene groups in patient isolates is
similar to reference genome 3D7
As a precursor to expression analysis, the twenty malaria cases
were investigated to determine the proportion of var gene groups
in the genomes of the infecting P. falciparum isolates to confirm
that the expected ratio of A:B:C genes is comparable to the 3D7
reference genome and other sequenced genomes [5,33]. We
quantitatively analysed var gene groups A, B and C by qPCR of
genomic DNA from tissue biopsies. The genomic distribution of
the three var groups indicated similar distributions in all diagnostic
categories and between organs.
Group A genes are highly expressed in organ
microvasculature
We used qRT-PCR to determine the expression levels of var
gene groups A, B and C in the infecting P. falciparum isolates. All
samples included in the analysis showed no significant differences in
observed raw CT values between clinical groups. Only three
samples; patient 62 heart, patient 75 gut and patient 78 brain were
excluded from the analysis due to failure of extraction or
amplification of cDNA. In CM2, group A var genes were expressed
at high levels in the brain compared to group B and C genes
(p= 0.001, ANOVA Bonferroni; Fig. 1A), consistent with periph-
eral blood studies linking group A expression with severe forms of
disease [19,21,23,24]. Group A genes were highly expressed in all
three organs and group B expression was lowest (p= 0.001). The
same pattern of expression was observed in PC cases (Fig. 1C),
despite their having a lower mean density of peripheral parasitaemia
at both admission and death compared to CM2 patients, and their
lack of the pathology characteristic of severe malaria (Table 1).
In contrast, CM1 patients had a unique pattern of expression of
the three var antigen groups (Fig. 1B), with group B var being the
most highly expressed and group C being the least expressed,
regardless of organ (p= 0.001).
Potential influence of HIV infection on pRBC
sequestration
We next investigated whether the disparate P. falciparum
antigen expression in CM1 infections might be associated with
unique host characteristics. CM1 accounted for a third of
confirmed CM cases in the clinicopathology study and could only
be identified definitively by post-mortem examination. The CM1
group did not significantly vary in other patient characteristics
outlined in Table 1 (age, time to death, admission or final
parasitaemia). However, CM1 patients were more likely to be
HIV+ than CM2 (p= 0.049; Kruskal-Wallis test) and we therefore
re-analysed the data taking this into account. Owing to the small
numbers of patients, we divided them into HIV-infected (HIV+)
and uninfected (HIV-), irrespective of malaria diagnosis.
Figure 1. Expression of var gene groups in the organs of paediatric hosts. Primers specific for var groups A, B and C were used to measure
their relative expression in tissue biopsies from fatal paediatric malaria patients. Panels A–C display hosts within diagnostic groups CM2 (A), CM1 (B)
and parasitaemic controls (C). Panels D–F represent P. falciparum populations in the brain (D), heart (E) and gut (F) of HIV-infected (HIV+) and
uninfected (HIV-) hosts. Each dot point represents analysis from a single organ biopsy from one patient and the horizontal lines depict the mean level
of expression for each group. In panels D–F, CM2/PC hosts are denoted by filled shapes and CM1 patients with open shapes. * p,0.05, ** p,0.005.
doi:10.1371/journal.ppat.1004537.g001
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Patient distribution was respective of their diagnostic group and in
each organ the var expression pattern in HIV- cases closely
resembled that of CM2 and PC, with high group A expression and
lowest expression of group B genes (Fig. 1D–F). A different pattern
was seen in HIV+ patients, with high and low expressing populations
for each var group. Group B genes were significantly over-expressed
in HIV+ cases compared to HIV- in all three organs (brain:
p=0.040; heart: p= 0.035 and gut: p=0.039, ANOVA Bonferroni).
Age is a potential confounder in this result; the HIV+ patients
were significantly older than HIV- (mean of 86.6 and 41.7 months,
respectively; p = 0.020). However, linear regression modeling
found no association between var expression levels and either
age, diagnosis or HIV status. The small sample size limits the
power of statistical analyses and we do not have indicators of the
stage of HIV disease in these patients who presumably span a
range of immunological deficiency.
The significant differences in var expression between HIV+ and
HIV- patients suggest a potential influence of HIV infection on
falciparum malaria but the relative influence of HIV, age and the
CM1 condition itself cannot be thoroughly assessed in our sample
population. An analysis of the impact of HIV on malaria
pathology is underway in the larger clinicohistopathology study
of which our patients are a subset.
Organ-derived pRBC populations express dominant var
genes
Expression of var transcripts in post-mortem organ samples was
further investigated by cloning and sequencing of DBL1a
transcripts. We will refer to each sequenced product as a ‘‘tag’’
and to each DBL1a sequence variant as a ‘‘type’’. From our pilot
study [27], we calculated that 100 tags were sufficient to characterise
var antigen expression within an organ sample. We attempted to
clone 100 tags, in two batches of 50, from each of brain, heart and
gut biopsies from 20 patients. Of these, 58 biopsies were successfully
processed from which we cloned a total of 5800 tags, 5153 of which
were identified as var-DBL1a sequence.
Tags were considered the same if they possessed .95%
nucleotide identity, which gave 613 discrete sequence types (S1
Table). 218 (35.6%) of var types were unique, cloned only once from
a single organ biopsy. This accounted for 4% of all tags sequenced.
Approximately a quarter of types (163; 26.6%), or 60% of tags, were
expressed in multiple organs of the same patient. We found a mean
of 39617 DBL1a types per patient, and 17610 per organ (Fig. 2).
There were no significant differences in the number of unique
sequence types identified between organs or diagnostic groups.
P. falciparum infections analysed from peripheral blood and in
vitro have been shown to express a predominant var gene at
population level, and the same was observed in these organ-derived
samples [2,22,34,35]. In our current analysis, dominance of
expression was defined as a sample from which at least 33% of
tags cloned from a single biopsy sample were identical, so that no
more than two sequences could be dominant in any one sample (in
theory this would be three, but we did not find so few sequences from
a single sample). Amongst our patients, 12 (60%) had a dominant var
type expressed in the brain, compared to 7 (35%) in the heart and 8
(40%) in the gut (Fig. 2). It was rare to find the same var type
expressed at dominant levels in more than one organ; this only
occurred in only two patients (Fig. 3; types 62B1-1 and 78E3-2.47).
Identical var transcripts detected in brain
microvasculature of multiple patients
The patients recruited into this study live in an area of high
malaria transmission with a complex degree of genetic variability
in the infecting isolates, and each of the 20 infections was
genetically distinct (S1 Figure and [30]). Such variability, and the
very low frequencies at which identical DBL1a types are observed
in multiple patients in peripheral blood studies [19,36,37],
originally led us to expect distinct var/PfEMP1 populations in
the 20 patients. However, our pilot study demonstrated consid-
erable overlap between DBL1a types expressed in a small number
of patients from a single malaria season [27]. Moreover, their
organ localisation was largely conserved. We therefore further
investigated these phenomena in this larger study.
140 (22.8%) of the 613 unique DBL1a types identified were
expressed in multiple patients (S2 Figure). When we considered
the number of times each type was detected, 57.5% of tags were
detected in more than one host, suggesting that DBL1a types with
high expression levels are more likely to be detected in multiple
patients. Individual var types were observed in up to 7 different
patients, and 37 (6%) of types were detected in at least three hosts
(Fig. 3).
15.0% of DBL1a types were detected in the same organ of
multiple patients (Fig. 3 and S2 Figure). 37.2% of var types
detected in the brain of one host were also detected in the brain of
another patient, with non-significantly lower overlap in the heart
and gut (32.4 and 28.2%, respectively). Those types observed at
higher frequency in any one sample were more likely to be
detected in others, such that 734 (41.1%) of all brain-derived
DBL1a tags were detected in multiple brain samples, whereas
overlap was 24.0% in the heart and 31.26% in gut biopsies (p,
0.005 for both).
These findings contrast with peripheral blood studies in which
fewer than 5% of identical DBL1a types are typically detected in
multiple patients, apart from in regions of low transmission
[19,36,37]. We compared our own peripheral blood samples from
a related study in which 17–100 DBL1a cDNA tags were
amplified and sequenced from each of 15 paediatric malaria
patients (S2 Figure). We observed that 17 (8.9%) of the total 191
DBL1a types were shared between patients, accounting for 26.1%
of all tags sequenced. Two patients had 9 of these shared types,
accounting for much of this overlap (S3B Figure, patients 92 and
95). This level of overlap is more in agreement with previous
peripheral blood studies, and suggests that there is a restricted
number of var/PfEMP1 variants expressed by sequestered pRBCs
in the microvasculature of the brain, gut and heart, compared to
those expressed in circulating populations.
We did not observe any associations between the number of
shared DBL1a types in organ samples, diagnostic group or
seasonality. In contrast to our pilot study, we observed no restricted
expression of particular var sequences within a malaria season.
Commonly detected var antigenic types
The var tags cannot be classified by A–C groups due to their
incomplete sequence of the DBL1a domain. To further investigate
the potential role of group A var genes in severe malaria, we
identified group A-like antigens by their possession of at least one
polymorphic sequence block drawn from a defined subset called
block-sharing group 1 and the presence of two conserved cysteine
residues, rather than the more common four. This was performed
using an analysis method kindly provided by Pete Bull and
described previously [25].
The majority (91.9%) of DBL1a types were of the non-A-type,
and only 8.8–11.9% of types were A-like in each organ (Fig. 2).
This is in contrast to the qRT-PCR results in which more than half
of CM2 and PC transcripts were group A (Fig. 1). When the
frequency of detection was taken into account the gut had only
7.9% of tags that were A-like, significantly less than the brain or
PfEMP1 Expression in Fatal Cerebral Malaria
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heart (12.6 and 11.9% respectively, p,0.005 for both). Isolates
from the peripheral blood study had a higher proportion of A-like
sequences (14.3%; S3A Figure).
Two DBL1a types were frequently detected in brain biopsies
(Fig. 3, starred). var62B1-1 (accession number KC678324) is A-
like, comprises a DBL1a1 domain and was the most commonly
detected type, being observed in seven hosts. In three CM2
patients: 62, 78 and 83, it was the mostly highly expressed var type
in the brain. It was also amplified in two additional brain samples
and in three samples each from heart and gut (see S2 Table for
details). A nearly identical sequence was previously detected in
Kilifi, Kenya, but this sequence had no particular distinguishing
Figure 2. Distribution of individual var/PfEMP1-DBL1a types in fatal paediatric malaria hosts. 100 DBL1a tags were amplified and
sequenced from each tissue biopsy and different sequence variants identified. Each pie graph represents all DBL1a types from a single organ of an
individual host shown in the brain (A), heart (B) and gut (C). Case numbers are shown in the upper left corner of each graph and they are arranged by
diagnostic group (CM, cerebral malaria; PC, parasitaemic controls). Tags are coloured by whether they are classified as group A-like var types (green)
or non-group A (blue).
doi:10.1371/journal.ppat.1004537.g002
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characteristics in that study (S1 Table; [38]). Downstream
sequencing revealed a DBL1a1.1-CIDR1a1.7-DBL2b3 structure
(accession number KC678109).
The other tag, var28B1-1 (accession number KC678110), was
also the dominant var antigen in three brain samples, and was the
second most expressed type in the brain of a fourth patient (Fig. 3,
starred). Interestingly, 4 of the 6 patients in which this type was
detected had a CM1 diagnosis. A highly similar sequence (97%
identity) was also detected in two severe malaria patients in Kilifi,
Kenya, where it was strongly associated with high rosetting rates
and may be disproportionally prevalent in East African isolates (S1
Table, [19]).
Figure 3. Distribution of individual var/PfEMP1-DBL1a types in the organs of fatal paediatric malaria hosts. Each pie graph represents
all DBL1a variants from a single organ of an individual host shown in the brain (A), heart (B) and gut (C). Case numbers are shown in the upper left
corner of each graph and they are arranged by diagnostic group (CM, cerebral malaria; PC, parasitaemic controls). These charts are identical to those
in Fig. 2 except that sections are shaded to highlight the DBL1a types that were detected in the highest number of different hosts. Further
information on these can be found in S1 Table. The two DBL1a types detailed in results are marked with an asterisk.
doi:10.1371/journal.ppat.1004537.g003
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Discussion
CM is one of the most dangerous and often fatal complications
of P. falciparum infection in African children. Using the unique
resources of the clinicopathological study of paediatric malaria in
Blantyre, Malawi, we have analysed sequestered populations of
pRBC in the brain, heart and gut of 20 cases of fatal malaria.
These patients hosted genetically unique parasite populations with
limited variation in their distribution between organ sites within
individual CM cases.
High expression of group A var has been linked to severe and
cerebral malaria in vitro and in peripheral blood samples from P.
falciparum-infected children [19,21,23,24,39]. Using qRT-PCR
targeting var groups A, B or C, we also found group A var
expressed at high levels in organ-derived parasite populations.
Group A var were upregulated in both CM2 cases and
parasitaemic controls. This suggests that group A antigens
promote higher rates of sequestration irrespective of the severity
of symptoms. Our third diagnostic category was CM1 in which
patients carried a heavy sequestered load of pRBC in the brain
with limited vascular pathology. In these patients, upregulation of
group B antigens was observed (Fig. 1). Transcription of group B
var has been associated with severe symptoms in a minority of
peripheral blood studies although there was no ability to
distinguish between CM1 and CM2 diagnoses in these sites
[20,23,40].
Previous clinical studies using the cloning and sequencing
approach have also sometimes found expression of group A-like
var associated with severe malaria, although the limited sequence
information contained in these tags has hindered further
classification of these antigens [17,18,19,25,41,42]. In contrast to
this, and to our own qRT-PCR results, group A var constituted no
more than 12% of var transcripts expressed by our organ-derived
parasite populations (Fig. 2). Using this method, equivalent
proportions of A-like var were expressed by parasites in CM1,
CM2 and PC patients.
There are clear disparities between the level of A-like var
expression measured using qRT-PCR and cloning methods. The
question is which of the two is the more reliable. Gatton et al
found good concordance between the two techniques using P.
falciparum isolate 3D7, and in a Ugandan study the same highly
expressed genes were detected by both methods in two laboratory
isolates and three of five clinical isolates [43,44]. However, both of
these studies used gene-specific primers for the qRT-PCR, not
degenerate primers as used in this study. In addition, they were
working with laboratory-adapted isolates whereas we were using
tissue samples in which P. falciparum genetic material constitutes
only a fraction of the total. This pushes both techniques to the
limits of their capacity. The use of degenerate primers risks
amplification of contaminating human DNA although any
reactions with multiple products visible by dissociation curve were
rejected.
The qRT-PCR data were consistent in multiple independent
replicates and cases for which this was not true were excluded. The
primers are not fully efficient for the myriad varieties of var genes
and may subsequently exhibit bias, especially in clinical isolates
with unknown var repertoires [20]. In order to ensure that the
genomic composition of var groups was similar to the reference
genome 3D7 and to highlight potential primer bias, we quantified
the ratio of var groups A, B, and C in the genomic DNA of all
twenty malaria cases by qRT-PCR and found no difference in
their relative proportions compared to 3D7. Differences we
observed in var group expression were therefore likely due to
transcriptional regulation and not primer bias. qRT-PCR
preferably uses probes specific for each var gene group [20].
However, it was extremely difficult to get a consistent product
using this technique on our post-mortem samples, presumably due
to high levels of human DNA. As more var genes are sequenced
from geographically diverse populations the design of degenerate
probes specific for each var group will improve.
The cloning and sequencing approach should be considered
semi-quantitative; particularly in this case where, because of the
low proportion of P. falciparum DNA in tissue samples, two
rounds of amplification were required. While interpreting the
proportion of each var tag with some caution, the data consistently
showed that var expression in individual organs tends to be
dominated by a limited number of sequences, and commonly by
one var/PfEMP1 type, particularly in the brain (Fig. 3). This is in
accordance with our pilot study and is also observed in circulating
populations [17,18,19,25,27,41,42]. Rarely was the same DBL1a
tag the dominant transcript in different organs of a single host.
Conversely, there was considerable overlap in var types
expressed in multiple hosts, often with organ localisation
conserved, even though the infecting isolates were genetically
distinct. Commonly observed var-DBL1a types may be partially
explained by recent modeling data showing a positive correlation
between transmission intensity and overlap of var repertoire,
independent of MOI [45]. Peripheral blood studies (including our
own) show low rates of identical var types being expressed in
multiple infections, which may imply that a restricted number of
var antigens are used by sequestering P. falciparum parasites in
the brain, heart and gut. Furthermore, we identified two var tags
that were expressed at high levels in the brains of 3–4 patients, and
in all organs each tag was detected in 6–7 individual hosts (S2
Table). This is a remarkable finding given the distinct genetic
barcodes of each infection. In areas of high transmission, severe
malaria typically affects those in the earliest years of life, but only a
minority of children develop severe disease syndromes. This
suggests that a limited set of parasites are capable of causing severe
disease before protective immunity is achieved [46,47]. This could
be due to a restricted antigenic repertoire with efficient or diverse
adhesive capabilities that are preferentially transcribed either
through hierarchical expression, switching at rapid on-rates or
slow off-rates, or both [1,2].
The overall lack of organ specificity of any var group is in
agreement with in vitro studies showing that pRBC selected on
cerebral endothelia, or expressing group A and A/B PfEMP1
containing DC13- or DC8 cassettes, promote cytoadherence
across a range of organ-derived endothelial cells [10,48]. The
receptor for pan-endothelial adhesion, EPCR, is not detectable in
the cerebral microvasculature of Malawian children who have
died of malaria but its critical role in pathogenesis may be earlier
[49]. The many studies linking high group A var expression in
circulating P. falciparum to severe symptoms suggest that there
must be high sequestration of group A-expressing pRBC at the
early symptomatic stage of disease when these patients would be
recruited [17,18,19,25,41,42].
This study demonstrates the inherent difficulties in examining
parasite expression in post-mortem samples but has nevertheless
illustrated that at this late stage of disease, similar proportions of
var gene transcripts are found in the brain, heart and gut of
paediatric malaria patients although the individual genes tran-
scribed differ. High expression of group B var is found in the less
common CM1 diagnostic group but the skewed characteristics of
these hosts do not allow us to distinguish between cause or effect.
In future, it would be interesting to investigate the frequency of var
domain subclasses or DCs if the considerable technical difficulties
of working with post-mortem samples can be overcome [8].
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Materials and Methods
Patient selection
Patients were admitted to the Paediatric Research Ward (PRW)
at the Queen Elizabeth Central Hospital (QECH), Blantyre,
Malawi, prior to their death. The clinical case definition for CM is
a Blantyre Coma Score of #2, peripheral P. falciparum
parasitaemia, and no other identifiable cause of coma. Anaemic
children (haematocrit ,15% at any time during hospitalisation)
were excluded from the study. Treatment that was prescribed to
each patient was as previously described [26]. The time between
admission and death varied between 30 minutes and 2.3 days with
a mean of 15:17 hours, and autopsies were performed a median of
865.5 hours following death. Following post-mortem examina-
tion, malaria cases were divided into three diagnostic groups
described above and more extensively elsewhere [26]. Details of
these patients are in Table 1.
Patients for the peripheral blood analysis were recruited from
the Paediatric Research Ward at Queen Elizabeth Central
Hospital, Malawi. They were identified by fever of .37uC or
history of fever in last 24 hours and P. falciparum asexual
parasitaemia of any density observed by light microscopy.
Nucleic acid extraction and processing
Approximately 0.460.461 cm tissue samples were collected at
autopsy, submerged in RNAlater (Qiagen, UK) and snap frozen in
liquid nitrogen. At extraction, samples were thawed on ice then
ground to powder using a liquid nitrogen-cooled mortar and
pestle. Half was put in 4 ml of DNA extraction buffer (10 mM
Tris-HCl, 0.1 M EDTA, 0.5% sodium dodecyl sulphate, 20 mg/
ml RNase A, pH 8.0) and half in 4 ml of Trizol (Sigma Aldrich,
UK) for RNA extraction.
For isolation of genomic DNA, samples were incubated at 37uC
for 60 minutes (min) and proteinase K added to a final
concentration of 0.1 mg/ml. Samples were incubated at 50uC
for 3 hours with regular mixing by gentle inversion. After cooling
to room temperature (RT), 5 ml of phenol:chloroform:isoamyl
alcohol (25:24:1; PCI) was added and samples were placed on a
rotary mixer for 10 min. After centrifugation at 5,000 g for
30 min, the aqueous phase was carefully transferred to a fresh
tube. If there was still a lot of material at the interface or some of
this material was carried over with the supernatant a second PCI
extraction was performed. Subsequently, 16 volume of chloro-
form was added and after 10 min on a rotary mixer the samples
were centrifuged at 5,000 g for 30 min and the aqueous phase
transferred to a fresh tube. DNA was precipitated with addition of
0.26 volume of 10 M ammonium acetate and 2 volumes of
ethanol. Precipitated DNA was transferred using a disposable
sterile loop to a fresh tube containing 1 ml of 70% ethanol, washed
by inversion and pelleted at 5,000 g for 10 min. The ethanol was
aspirated and the wash step repeated. The pellets were air dried
and resuspended in 0.2–1 ml of 10 mM Tris-HCl, 1 mM EDTA,
pH 8.0 depending on the pellet size, resuspended by overnight
incubation at RT and stored at 4uC.
For extraction of RNA, samples in Trizol were centrifuged at
12,000 g at 4uC to pellet insoluble material and the supernatant
transferred to a new tube. After 5 min incubation at RT, a 0.26
volume of chloroform was added and the tubes shaken for 15
seconds (sec). Following 3 min incubation at RT, the samples were
centrifuged at 12,000 g for 30 min at 4uC. The aqueous phase was
transferred to four 1.5 ml tubes and 0.5 ml of isopropanol added
to each. The RNA was precipitated by overnight incubation at
4uC followed by centrifugation at 12,000 g for 30 min at 4uC. The
pellets were each washed in 1 ml of 75% ethanol, centrifuged at
7,500 g for 5 min at 4uC then aspirated and air dried. The pellets
were each resuspended in 20 ml of RNA storage solution (Life
Technologies, UK) and stored at 280uC. This method is adapted
from Kyes et al. [50].
5–10 ml aliquots of RNA were treated with DNase I to remove
contaminating genomic DNA using the DNA-free RNA kit
(Cambridge Bioscience, UK) according to manufacturer’s instruc-
tions. Removal of DNA was confirmed by performing two rounds
of var universal PCR as described below (with no reverse
transcription step). 1 ml of RNA was also assessed using a
NanoDrop (Nanodrop, UK) and degraded samples were discard-
ed. cDNA was synthesised using the Retroscript kit (Life
Technologies, UK); briefly, 2 ml of DNA-free RNA was mixed
with 50 pmol of random decamers and 8 ml of nuclease-free water
and incubated at 65uC for 5 min. Samples were briefly centrifuged
then placed on ice for 5 min. To each sample was added 2 ml of
RT buffer (0.5 M Tris-HCl, pH 8.3, 0.75 M KCl, 30 mMMgCl2,
50 mM DTT), 30 pmol of deoxynucleotide triphosphates
(dNTPs), 10 units of RNase inhibitor and 100 units of MMLV-
reverse transcriptase. cDNA was synthesised at 42uC for 60 min
and then the reverse transcriptase was inactivated at 92uC for
10 min. The same cDNA samples were used for both qRT-PCR
and var amplification and cloning.
P. falciparum-infected peripheral blood samples were subjected
to a pre-lysis step whereby 5 ml of 10% saponin was added per
200 ml of blood, vortexed vigorously and then centrifuged at
6,000 g for 5 min. The supernatant was discarded and the pellet
was resuspended in 0.2 ml of 16 phosphate buffered saline
(pH 7.2–7.4; PBS), at which point the samples were processed
using the QiaAmp Blood Miniprep Kit (Qiagen, UK) according to
manufacturer’s instructions.
Nucleic acid amplification
Typing of msp2 was performed as described in Snounou et al.
[28]. DNA quantification and barcoding was performed using the
protocol of Daniels et al. [29] using SYBR green detection for
quantification and Taqman for barcoding (Applied Biosystems,
UK). All parasite DNA concentrations were standardised to
0.001 ng/ml before PCR analysis.
For differential var group transcriptional analysis, quantitative
real-time polymerase chain reaction (qRT-PCR) specific for all 3
var gene groups using a method modified from Kaestli et al. [20].
Prior to qRT-PCR, 1 mL of 0.001 ng/ml cDNA or gDNA samples
were amplified in a primary PCR on a Veriti thermocycler model
9902 (Applied Biosystems, UK). A 50 ml reaction containing
2 mM of MgCl2, 0.4 M of dNTPs, 0.25 units of Taq DNA
polymerase (Invitrogen, UK) and 400 nM of each primer was
amplified using an initial incubation of 94uC for 5 min followed by
14 cycles for gDNA and 16 cycles for cDNA of the following
conditions: 95uC for 30 sec, 52uC for 1 min and 64uC for 70 sec
in 50 ml volume. The forward primer for each var group was A:
59-AACTTACCATAAATTATCATCAAA, B: 59-CTCATWTA-
TAATTTTASAAAATAWAWAAAAC, C: 59-AATATTCATA-
TTCCCACATTRTCATATAT and reverse primer DBL1arev:
59-CCWATRKCDGCAAAACTBCKWGC. The primary PCR
product was checked on 1% agarose gel electrophoresis and lack of
a visible band indicated that the subsequent RT-PCR would not
exceed the linear range.
qRT-PCR was performed on a 7900HT Fast Real-Time PCR
System (Applied Biosystems) using primers targeting group A, B or
C var genes designed from alignments of 59 untranslated region
var sequences. These reactions used 2 ml of primary product in
10 ml volume containing 16 SYBR Green and a final primer
concentration of 900 nmol/L using forward primers described
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above and reverse primers A: 59-TCACCTACAACAAATRTAA-
TAAA, B: 59-TTAWGGGAGTATWGTDATATGGTAGAAT
and C: 59-ATTATGTGGTAATATCATGTAATGG. An initial
incubation of 94uC for 5 min was followed by 40 cycles of 95uC
for 30 sec, 54uC for 1 min and 64uC for 70 sec.
The samples were divided by diagnosis in 384-well plates using
3D7 DNA as a positive control. All DNA samples were run in
triplicate and were included in the analysis if the cycle-threshold
(CT) was within the linear range between 15 and 31 and a product
dissociation curve with a melting temperature difference of ,1uC.
Each plate that did not meet the above stated standards was
discarded and the samples were repeated from the cDNA.
Standard curves were linear over a 6-phase dilution series of
3D7 gDNA ranging between 0.8–0.00008 ng/ml, each in tripli-
cate. The PCR efficiency (E) was calculated using the formula
E=10(1/-slope)-1. The slope was analysed close to 23.47 as
recommended by the manufacturer (Applied Biosystems) to
maintain maximum efficiency. The mean efficiencies of three
independent standard curves with high reproducibility were 98%
for var group A, 87% for var group B, and 96% for var group C.
The Kaestli et al. method was used to convert raw CT values
into approximate copy numbers using the formula C/EDCT, where
C is the number of gene copies in var groups A, B, or C in the
genome of the plate calibrator (3D7); E is the amplification
efficiency of the corresponding primer pair; and DCT is the
difference in average CT values between the sample and the
corresponding var group using 3D7 DNA [20]. Finally, var
transcript abundance was expressed as a proportion of total
transcript of all var groups per sample.
In order to ensure that the genomic composition of the var
subgroups was similar to the 3D7 reference genome and other
sequenced genomes, the ratio of var gene groups A, B and C in
genomic DNA of the twenty malaria cases were also quantified by
qRT-PCR. As expected, the genomic distribution of the three var
subgroups was similar among hosts from different clinical
diagnostic groups as well as between the brain, heart and gut,
with 7% of the overall genes amplified belonging to var group A,
76% to var group B and 16% to var group C.
Amplification and sequencing of individual var
sequences
Amplification of DBL1a tags used a nested PCR approach of
Duffy et al. [51]. The first round utilised 2 ml of cDNA and var-
DBL1a primers 59-GGIGCITGYGCICCRTWYMG and 59-
TCTTCIGYCCATTCCTCGAACCA with a final concentration
of 4 mM of MgCl2, 0.2 M of dNTPs, 1 mM of each primer and
0.25 units of Taq DNA polymerase (Invitrogen, UK). Following an
initial incubation of 95uC for 3 min there were 50 cycles of 93uC
for 30 sec, 55uC for 30 sec and 72uC for 1 min, with a final
extension at 72uC for 7 min. In the second round, primers 59-
GCACGMAGTTTYGCNGATATAGG and 59-ARATAYTGN-
GGSACRTARTCNARAT were used under the same conditions
excepting an extension temperature of 52uC and 3.8 mM MgCl2.
PCR products were cloned into the pGEM-T-Easy Vector System
I (Promega, UK) according to manufacturer’s instructions.
Plasmids were extracted using the PureYield Plasmid Miniprep
System (Promega, UK) as recommended by the manufacturer.
Long range PCR on var62B1-1 (GenBank accession number
KC678324) using specific internal forward primer 59-AGAAAC-
GATTGGTGGACGGTT A and degenerate DBLb degenerate
reverse primer 59- TTTRCARTACCATTCKGCCC. Products
were amplified from genomic DNA extracted from a gut biopsy of
patient 62 using Takara LA Taq DNA Polymerase (Cambrex, UK)
and 35 cycles of 98uC for 15 s and 68uC for 7 min. Products were
cloned using the TOPO-XL PCR Cloning Kit (Invitrogen, UK)
according to manufacturer’s instructions. DNA sequencing was
performed at the Wellcome Trust Sanger Institute.
Identical DBL1a tags from each organ were distinguished using
BLASTclust (toolkit.tuebingen.mpg.de/blastclust), defined as .
95% identity at nucleotide level. Stepwise comparisons were made
between tag sets from each organ and then from each patient to
identify the frequency of each var type within organ samples and
where they were shared with other organ samples and between
hosts. After each unique tag was identified, sequences were aligned
using clustalw (http://www.genome.jp/tools/clustalw/) and se-
quence data were submitted to the DDBJ/EMBL/GenBank
databases under accession numbers KC678109–KC678690.
Searches for identity with P. falciparum sequenced genomes were
performed using BLAST at PlasmoDB (http://www.plasmodb.
org), the Broad Institute (http://www.broadinstitute.org/
annotation/genome/plasmodium_falciparum_spp/MultiHome.
html) and the National Center for Biotechnology Information
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). All online tools used
default settings. Identification of var group A-like sequences was
performed using a perl script kindly provided by Peter Bull and
described in [52]. This script identifies ‘‘group A-like’’ var tags by
the presence of two conserved cysteine residues (compared to
another other number between 0–6) and the presence of at least
one of 573 polymorphic sequence blocks known as block-sharing
group 1.
Statistical methods
Var expression graphs were drawn using GraphPad Prism
version 6.0 (GraphPad Software, USA) and all statistical analyses
were performed using Stata version 12.0 (StataCorp, USA).
Within-group comparisons of var group expression between
individual hosts were done by analysis of variance (ANOVA)
corrected by the Bonferroni-Dunn method. The non-parametric
Kruskal-Wallis test was used to compare the distribution of var
gene groups across the different clinical characteristics; age,
diagnosis and HIV status. If the Kruskal Wallis test was significant,
pair-wise tests were done using Mann-Whitney U test to identify
groups that had a significant difference in means. Multivariate
linear regression model was performed to assess association
between var gene group expression and either age after adjusting
for diagnosis or HIV status. Categorical outcomes were summa-
rized using percentages. Fisher’s exact test was used to compare
proportions between two groups. All tests were declared significant
if p#0.05.
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Supporting Information
Figure S1 Distribution of P. falciparum genetic variants in the
organs of paediatric malaria hosts. Patients are arranged by
diagnostic group (CM, cerebral malaria; PC, parasitaemic
controls). A. Barcoding analysis. Each box represents a single
host and each horizontal line represents a single organ as labeled
on left. 24 SNPs are shown for each patient with major allele in
dark grey, minor allele in light grey, heterozygous calls in orange
and failed calls blank. B. msp2 analysis. Boxes represent hosts and
organs as in A, and green shading denotes an FC27 or IC allele.
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Where these are vertically aligned within a patient, the genetic
variants are considered identical.
(TIF)
Figure S2 Distribution of individual var/PfEMP1-DBL1a types
in the organs of fatal paediatric malaria hosts. Each pie graph
represents all DBL1a variants from a single organ of an individual
host shown in the brain (A), heart (B) and gut (C). Case numbers
are shown in the upper left corner of each graph and they are
arranged by diagnostic group (CM, cerebral malaria; PC,
parasitaemic controls). These charts are identical to those in
Fig. 2 except that sections are shaded to identify DBL1a types
detected in a single host (grey) or in multiple hosts (orange).
(TIF)
Figure S3 Distribution of individual var DBL1a types in the
peripheral blood of paediatric malaria hosts. Each graph
represents an individual patient. Case numbers are shown in the
upper left corner of each graph. In A, sections are coloured by
whether they are classified as group A-like var types (green) or
non-group A (blue). In B, sections are shaded to identify DBL1a
types detected in a single host (grey) or in multiple hosts (orange).
(TIF)
Table S1 Var tags that were highly expressed and/or detected in
multiple patients are listed with similarity matches to the 3D7
reference genome, other P. falciparum genome databases and
from the nucleotide sequence database at the National Centre for
Biotechnology Institute.
(DOCX)
Table S2 GenBank accession numbers for all var sequence tags.
Shading indicates in which patient and organ the tags were
detected.
(XLSX)
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